North American Pharma-Biotech Sector to Wrap up Construction on 157 Projects Worth $1.3 Billion in Third-Quarter 2014
Attachment: Pharma-Biotech Completions 3Q14
SUGAR LAND--August 20, 2014--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Midway through the third quarter of 2014, the Pharmaceutical-Biotech Industry is busy finishing an impressive array of capital construction projects. The sector is on target to complete construction on a total of 156 North American capital projects. A recent survey of reported projects in Industrial Info's Pharmaceutical Tracker - Online Database reveals that the projects represent a total investment value (TIV) of $1.3 billion.
Within this article: Details on projects from companies such as Genzyme, GlaxoSmithKline (NYSE:GSK), Ipsen Biosciences and Biomed Realty Trust.
